Cancer and the gut microbiota: An unexpected link

Science Translational Medicine

Volumn 7, Issue 271, 2015, Pages

  Zitvogel, Laurence ^a,b   Galluzzi, Lorenzo ^a,b,c,d   Viaud, Sophie ^a,b   Vétizou, Marie ^a,b   Daillère, Romain ^a,b   Merad, Miriam ^e   Kroemer, Guido ^a,b,c,d,f  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSERM   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIOCIN; BUTYRIC ACID; CANCER VACCINE; CPG OLIGODEOXYNUCLEOTIDE; CYCLOPHOSPHAMIDE; FLUOROURACIL; FRUCTOSE OLIGOSACCHARIDE; HERBACEOUS AGENT; INULIN; IRINOTECAN; OXALIPLATIN; PHY 906; PLATINUM DERIVATIVE; PREBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; CANCER THERAPY; CARCINOGENESIS; COLORECTAL CANCER; DIARRHEA; DYSBIOSIS; GASTROINTESTINAL TOXICITY; HUMAN; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE INJURY; MALIGNANT TRANSFORMATION; MUCOSAL IMMUNITY; NEOPLASM; NONHUMAN; PHARMACODYNAMICS; TUMOR GROWTH; GASTROINTESTINAL TRACT; MICROBIOLOGY; MICROFLORA; NEOPLASMS; PATHOLOGY;

ANTINEOPLASTIC AGENTS; CARCINOGENESIS; DYSBIOSIS; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; NEOPLASMS;

EID: 84921742288     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3010473     Document Type: Article

References (32)

1. R. F. Schwabe, C. Jobin, The microbiome and cancer. Nat. Rev. Cancer 13, 800-812 (2013).
2. C. L. Maynard, C. O. Elson, R. D. Hatton, C. T. Weaver, Reciprocal interactions of the intestinal microbiota and immune system. Nature 489, 231-241 (2012).
3. N. Kamada, S. U. Seo, G. Y. Chen, G. Núñez, Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 13, 321-335 (2013).
4. J. L. Wang, C. H. Chang, J. W. Lin, L. C. Wu, L. M. Chuang, M. S. Lai, Infection, antibiotic therapy and risk of colorectal cancer: A nationwide nested case-control study in patients with Type 2 diabetes mellitus. Int. J. Cancer 135, 956-967 (2014).
5. M. Bonnet, E. Buc, P. Sauvanet, C. Darcha, D. Dubois, B. Pereira, P. Déchelotte, R. Bonnet, D. Pezet, A. Darfeuille-Michaud, Colonization of the human gut by E. coli and colorectal cancer risk. Clin. Cancer Res. 20, 859-867 (2014).
6. J. C. Arthur, E. Perez-Chanona, M. Mühlbauer, S. Tomkovich, J. M. Uronis, T. J. Fan, B. J. Campbell, T. Abujamel, B. Dogan, A. B. Rogers, J. M. Rhodes, A. Stintzi, K. W. Simpson, J. J. Hansen, T. O. Keku, A. A. Fodor, C. Jobin, Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120-123 (2012).
7. Y. Zhan, P. J. Chen, W. D. Sadler, F. Wang, S. Poe, G. Núñez, K. A. Eaton, G. Y. Chen, Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury. Cancer Res. 73, 7199-7210 (2013).
8. P. Louis, G. L. Hold, H. J. Flint, The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661-672 (2014).
9. S. Yoshimoto, T. M. Loo, K. Atarashi, H. Kanda, S. Sato, S. Oyadomari, Y. Iwakura, K. Oshima, H. Morita, M. Hattori, K. Honda, Y. Ishikawa, E. Hara, N. Ohtani, Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97-101 (2013).
10. D. H. Dapito, A. Mencin, G. Y. Gwak, J. P. Pradere, M. K. Jang, I. Mederacke, J. M. Caviglia, H. Khiabanian, A. Adeyemi, R. Bataller, J. H. Lefkowitch, M. Bower, R. Friedman, R. B. Sartor, R. Rabadan, R. F. Schwabe, Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21, 504-516 (2012).
11. C. Xuan, J. M. Shamonki, A. Chung, M. L. Dinome, M. Chung, P. A. Sieling, D. J. Lee, Microbial dysbiosis is associated with human breast cancer. PLOS One 9, e83744 (2014).
12. C. M. Velicer, S. R. Heckbert, J. W. Lampe, J. D. Potter, C. A. Robertson, S. H. Taplin, Antibiotic use in relation to the risk of breast cancer. J. Am. Med. Assoc. 291, 827-835 (2004).
13. Y. Touchefeu, E. Montassier, K. Nieman, T. Gastinne, G. Potel, S. Bruley des Varannes, F. Le Vacon, M. F. de La Cochetière, Systematic review: The role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - Current evidence and potential clinical applications. Aliment. Pharmacol. Ther. 40, 409-421 (2014).
14. Y. D. Nam, H. J. Kim, J. G. Seo, S. W. Kang, J. W. Bae, Impact of pelvic radiotherapy on gut microbiota of gynecological cancer patients revealed by massive pyrosequencing. PLOS One 8, e82659 (2013).
15. R. R. Jenq, C. Ubeda, Y. Taur, C. C. Menezes, R. Khanin, J. A. Dudakov, C. Liu, M. L. West, N. V. Singer, M. J. Equinda, A. Gobourne, L. Lipuma, L. F. Young, O. M. Smith, A. Ghosh, A. M. Hanash, J. D. Goldberg, K. Aoyama, B. R. Blazar, E. G. Pamer, M. R. van den Brink, Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J. Exp. Med. 209, 903-911 (2012).
16. I. Von Bültzingslöwen, I. Adlerberth, A. E. Wold, G. Dahlén, M. Jontell, Oral and intestinal microflora in 5-fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria. Oral Microbiol. Immunol. 18, 278-284 (2003).
17. B. D. Wallace, H. Wang, K. T. Lane, J. E. Scott, J. Orans, J. S. Koo, M. Venkatesh, C. Jobin, L. A. Yeh, S. Mani, M. R. Redinbo, Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330, 831-835 (2010).
18. W. Lam, S. Bussom, F. Guan, Z. Jiang, W. Zhang, E. A. Gullen, S. H. Liu, Y. C. Cheng, The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Sci. Transl. Med. 2, 45ra59 (2010).
19. N. Iida, A. Dzutsev, C. A. Stewart, L. Smith, N. Bouladoux, R. A. Weingarten, D. A. Molina, R. Salcedo, T. Back, S. Cramer, R. M. Dai, H. Kiu, M. Cardone, S. Naik, A. K. Patri, E. Wang, F. M. Marincola, K. M. Frank, Y. Belkaid, G. Trinchieri, R. S. Goldszmid, Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342, 967-970 (2013).
20. S. Viaud, F. Saccheri, G. Mignot, T. Yamazaki, R. Daillère, D. Hannani, D. P. Enot, C. Pfirschke, C. Engblom, M. J. Pittet, A. Schlitzer, F. Ginhoux, L. Apetoh, E. Chachaty, P. L. Woerther, G. Eberl, M. Bérard, C. Ecobichon, D. Clermont, C. Bizet, V. Gaboriau-Routhiau, N. Cerf-Bensussan, P. Opolon, N. Yessaad, E. Vivier, B. Ryffel, C. O. Elson, J. Doré, G. Kroemer, P. Lepage, I. G. Boneca, F. Ghiringhelli, L. Zitvogel, The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342, 971-976 (2013).
21. B. Björkholm, C. M. Bok, A. Lundin, J. Rafter, M. L. Hibberd, S. Pettersson, Intestinal microbiota regulate xenobiotic metabolism in the liver. PLOS One 4, e6958 (2009).
22. Y. Eriguchi, S. Takashima, H. Oka, S. Shimoji, K. Nakamura, H. Uryu, S. Shimoda, H. Iwasaki, N. Shimono, T. Ayabe, K. Akashi, T. Teshima, Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. Blood 120, 223-231 (2012).
23. + T cells via TLR4 signaling. J. Clin. Invest. 117, 2197-2204 (2007).
24. J. P. Zackular, N. T. Baxter, K. D. Iverson, W. D. Sadler, J. F. Petrosino, G. Y. Chen, P. D. Schloss, The gut microbiome modulates colon tumorigenesis. MBiol. 4, e00692-e13 (2013).
25. M. T. Liong, Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and in-vivo evidence. Int. J. Mol. Sci. 9, 854-863 (2008).
26. G. Capurso, M. Marignani, G. Delle Fave, Probiotics and the incidence of colorectal cancer: When evidence is not evident. Dig. Liver Dis. 38 (Suppl 2), S277-S282 (2006).
27. L. G. Bermúdez-Humarán, C. Aubry, J. P. Motta, C. Deraison, L. Steidler, N. Vergnolle, J. M. Chatel, P. Langella, Engineering lactococci and lactobacilli for human health. Curr. Opin. Microbiol. 16, 278-283 (2013).
28. J. Pol, N. Bloy, F. Obrist, A. Eggermont, J. Galon, W. HervéFridman, I. Cremer, L. Zitvogel, G. Kroemer, L. Galluzzi, Trial Watch: DNA vaccines for cancer therapy. Oncolmmunology 3, e28185 (2014).
29. + T cells is crucial to inhibit the growth of mucosal tumors. Sci. Transl. Med. 5, 172ra20 (2013).
30. A. Hamad, K. C. Fragkos, A. Forbes, A systematic review and meta-analysis of probiotics for the management of radiation induced bowel disease. Clin. Nutr. 32, 353-360 (2013).
31. H. S. Taper, M. B. Roberfroid, Possible adjuvant cancer therapy by two prebiotics - Inulin or oligofructose. In Vivo 19, 201-204 (2005).
32. E. Holmes, J. Kinross, G. R. Gibson, R. Burcelin, W. Jia, S. Pettersson, J. K. Nicholson, Therapeutic modulation of microbiota-host metabolic interactions. Sci. Transl. Med. 4, 137rv6 (2012).